The scrapie prion protein (PrP Sc ) has been shown to induce apoptosis of rat cortical neurons in vitro. Here we demonstrate that the toxic effect displayed by PrP Sc can be blocked by sulfated colominic acid (polymer of N-acetylneuraminic acid). This compound acts neuroprotectively at a concentration of 50.3 mg/ml when preincubated with the neurons or PrP Sc . Rat cortical cells also undergo apoptosis after incubation with the HIV-1 coat protein gp120 in vitro. This effect was abolished also by sulfated colominic acid when preincubated with the cells or gp120. Addition of 0.3 mg/ml of compound resulted in an increase in cell viability by about 1.6 ± 1.9-fold compared to cultures incubated for 18 h with 30 ng/ml of PrP Sc or 20 ng/ml of gp120 alone (containing about 40% viable cells). Sulfated colominic acid does not act as antagonist of NMDA receptor channels at concentrations of up to 3 mg/ml when co-administered with 100 mg/ml of NMDA. It displayed a strong cytoprotective effect on human T lymphoblastoid CEM cells exposed to HIV-1; a 50% protection occurred after preincubation of the cells with 0.43 mg/ml of compound. At the same concentration, the compound caused an inhibition of HIV-1-induced syncytium formation. Sulfated colominic acid may be a promising compound for treatment of dementia caused by PrP Sc and HIV-1 infections.
Introduction
The scrapie prion protein (PrP Sc ) is able to induce apoptosis in neuronal cells ± both in vitro and in vivo (Fairbairn et al, 1994; Giese et al, 1995; Lucassen et al, 1995) . PrP Sc is considered as the causative agent of transmissible neurodegenerative diseases, including Creutzfeldt-Jakob disease and Gerstmann-Stra Èussler syndrome in humans, and scrapie and bovine spongiform encephalopathy in animals (Prusiner, 1994) . This deleterious protein is thought to be formed by conversion of the putative a-helices of the normal cellular prion protein (PrP C ) into b-sheets (Gasset et al, 1992) . The mechanism underlying the neurotoxic effect of PrP Sc and of its peptide fragment, PrP 106 ± 126 (Forloni et al, 1993; Perovic et al, 1995) is not yet fully understood. PrP C is present predominantly in the brain, where it may play a role in synaptic function (Collinge et al, 1994) , but lower amounts of this protein have also been detected in other tissues (Bendheim et al, 1992) . PrP C may contribute to the integrity of synapses containing GABA receptors (Collinge et al, 1994) and has been shown to increase the synaptosomal levels of intracellular free calcium through an interaction with voltagesensitive calcium channels (Whatley et al, 1995) . The PrP Sc has been shown to affect ionotropic glutamate receptors, especially the N-methyl-Daspartate (NMDA) receptor; this effect can be prevented by NMDA receptor antagonists . The PrP Sc -induced neurotoxicity seems to be associated with the production of reactive oxygen species (ROS), resulting in apoptosis of the cells (Schro È der et al, 1999) . Furthermore, the PrP 106 ± 126 peptide has been shown to decrease the levels of intracellular glutathione in neuronal cells (Perovic et al, 1996 .
At present, only a few drugs are known which may protect animals against PrP Sc infection and suppress PrP Sc -induced neurotoxicity: (i) polyanio-nic glycans, including pentosan sulfate and dextran sulfate, have been shown to prolong the incubation period and to inhibit PrP Sc formation in rodents (Diringer and Ehlers, 1991) , most likely by reducing of the amount of PrP C on the cell surface through enhanced endocytosis of PrP C (Shyng et al, 1995) ; (ii) the polyene macrolide antibiotic, amphotericin B (Pocchiari et al, 1989) , and its derivative, MS-8209 (Adjou et al, 1995) , also cause a prolongation of the incubation period of PrP Sc -infected mice; (iii) the accumulation of PrP Sc could also be blocked by Congo red (Caughey and Race, 1992) and (iv) the anthracycline 4'-iodo-4'-deoxy-doxorubicin, which bind to amyloid ®brils (Tagliavini et al, 1997) ; (v) the neutotoxic effect displayed by PrP Sc was found to be prevented by antagonists of NMDA receptor channels, such as memantine and MK-801 Perovic et al, 1995; Brown et al, 1996) ; and (vi) the triaminopyridine¯upirtine, a clinically used non-opiod analgesic drug, was found to display in vitro a strong cytoprotective effect on neurons treated with PrP Sc or its toxic fragment, PrP 106 ± 126 (Perovic et al, 1994 . This drug enhances the level of the antiapoptotic protein Bcl-2 and normalizes the level of intracellular glutathione (Perovic et al, 1996 .
Apoptosis is thought also to be one major mechanism responsible for the cytopathic effect of the human immunode®ciency virus type 1 (HIV-1), resulting in the progressive loss of neurons and lymphocytes (in particular CD4 + lymphocytes) during the progression of the disease (Gougeon et al, 1993; Schattner and Laurence, 1994) . We described that neurons undergo cell death following exposure to the isolated viral glycoprotein gp120 in vitro (Mu È ller et al, 1992) . This deleterious effect could be prevented, like PrP-induced apoptosis, by the NMDA receptor channel blockers, memantine and MK-801 (Mu È ller et al, 1992) . Gp120 is known to bind to the surface glycoprotein CD4, which is expressed on a subset of T-cells and macrophages (Sattentau and Weiss, 1988) . The binding site for gp120 at the neurons is not known. Gp120 does not interact with the NMDA receptor directly . We found that exposure of neuronal cells to gp120 causes an activation of phospholipase A 2 resulting in an increased release of arachidonic acid which in turn may sensitize the NMDA receptor . Recent reports indicate that gp120-mediated apoptosis of neuronal cells can be prevented by compounds which lower the load of ROS .
Until now there are no effective therapies for treatment of apoptosis induced by PrP Sc , or gp120. Recently it has been reported that sulfated colominic acid exhibits anti-HIV-1 activity (Yang et al, 1996) . Colominic acid is a homopolymer of Nacetylneuraminic acid, containing a-2,8 ketosidic linkages between the sugar moieties (McGuire and Binkley, 1964) . Here we show that sulfated colominic acid (Figure 1 ) is a potent inhibitor of both PrP Sc and gp120-induced neuronal cell death.
Results
Neuroprotective effect of sulfated colominic acid
Neuroprotective effect on PrP Sc -treated neuronal cultures Treatment of rat cortical cells with 30 ng/ml of PrP Sc entrapped into liposomes for 18 h resulted in a signi®cant (P50.01) reduction of cell viability compared to untreated control (decrease in A 595 nm value by 51% in MTT assay; Figure 2B ). In parallel with the decrease in cell viability, a strong and signi®cant (P50.01) increase in apoptosis (by 4.6-fold based on A 405 nm value in cell-death detection ELISA which measures the presence of soluble histone-associated DNA fragments) was observed in the presence of 30 ng/ml of PrP Sc compared to the assay in the absence of PrP Sc ( Figure 2A ). No signi®cant effect on both apoptosis ( Figure 2A ) and cell viability ( Figure 2B ) was observed using a detergent liposome extract, which was prepared from a pelleted fraction from uninfected normal brain. Addition of sulfated colominic acid partially abolished the cytotoxic effect displayed by PrP Sc . After preincubation with the compound for 30 min, the viability of the cells signi®cantly (P50.01) increased from 42% (A 595 nm 0.28; no compound) to 65% (A 595 nm 0.44; cultures treated with 0.3 mg/ml of sulfated colominic acid) compared to control cultures without PrP Sc and compound (A 595 nm 0.67; set at 100%; Figure 3B ). At higher concentrations, 1 or 3 mg/ml of sulfated colominic acid, the drugmediated cytoprotection became 480% ( Figure  3B ). Pretreatment of the PrP Sc -containing liposomes with 1 mg/ml of sulfated colominic acid (5 h, 48C) prior to addition to the neurons also resulted in a signi®cant (P50.01) cytoprotective effect; increase in cell viability (A 595 nm value) from 0.32+0.06 to 0.55+0.06 (47+8% to 80+9%, compared to untreated control; n=10; not shown in Figure 3B ). The cytoprotective effect of sulfated colominic acid could also be observed when the extent of apoptosis of the cells (presence of histone-associated DNA Figure 1 Structure of sulfated colominic acid. Figure 3A) . At higher concentrations, 1 and 3 mg/ml, the effect of sulfated colominic acid was even more pronounced; decrease in apoptosis to A 405 nm 0.23 and A 405 nm 0.19, respectively. A sig- Figure 2 Induction of neuronal cell death by PrP Sc and gp120 in vitro. The cultures remained either untreated (= Co) or were treated with PrP Sc -containing detergent liposome preparation (30 ng/ml of PrP Sc ) (= PrPSc), or a detergent liposome extract, prepared from the pelleted fraction from an equivalent amount of uninfected brain lacking PrP Sc , used as a negative control (= Co-Lip). Further cultures were treated with gp120 (20 ng/ml) in the absence (= gp120) or presence of 100 ng/ml of the lectin from Gerardia savaglia (= gp120+GL) and Narcissus pseudonarcissus (= gp120+NPL). After a total incubation period of 18 h apoptosis (presence of histone-associated DNA fragments in the cytoplasm) was determined by the cell-death detection ELISA (A) and viability was assayed using the MTT assay (B). The development of color in the peroxidase substrate buffer of the ELISA was determined photometrically by measuring the absorbance values at 405 nm; the formation of the formazan dye in MTT assay was monitored at 595 nm. The means+s.d. of ten independent experiments are shown. The statistical signi®cance of changes was analyzed with a one-way ANOVA, followed by Scheffe Â's test; **P50.01, compared with untreated control cultures; ##P50.01, compared with cultures treated with gp120 alone.
Figure 3 Neuroprotective effect of sulfated colominic acid on PrP
Sc -induced cytotoxic effect on rat cortical cells in vitro. The cells were incubated in the absence or presence of PrP Sc ; where indicated different concentrations of sulfated colominic acid were added to the cultures 30 min prior to the addition of PrP Sc (®lled bars). In one experiment, the sulfated colominic acid (1 mg/ml) was added 2 h after addition of PrP Sc (open bar). After a total incubation period of 18 h apoptosis (presence of histone-associated DNA fragments in the cytoplasm) was determined by the cell-death detection ELISA (A) and viability was assayed using the MTT assay (B). Ten independent experiments were performed; means+s. Figure 3A ). The sulfated colominic acid was found to be fully active only if the cells or PrP Sc were preincubated with the compound. Addition of 1 mg/ml of sulfated colominic acid to the cultures 2 h after addition of PrP Sc resulted in a decrease in apoptosis to only A 405 nm 0.32 (P50.05; Figure 3A ) and an increase in viability to only A 595 nm 0.41 (P50.05; Figure 3B ).
The PrP Sc -induced cytotoxicity was completely abolished if the preparation was preincubated with the R073 antibody (ratio PrP Sc : R073, 15 mg : 2500 mg) prior to the addition to the neurons; the antibody alone did not affect the viability of the cells (not shown; see also Mu È ller et al, 1993) .
The effect of sulfated colominic acid alone on the neuronal cells is shown in Figure 4 . The results revealed that, in the concentration range tested, the compound does not signi®cantly affect the naturally occurring neuronal cell death, as determined in cell-death detection ELISA ( Figure 4A ) and MTT assay ( Figure 4B ).
Treatment of neuronal cell cultures with PrP Sc or sulfated colominic acid might result in glial cell proliferation. Therefore, the cellular composition of the cultures was determined before and after the test period. However, the results revealed that the content of glial cells did not markedly change during the incubation period (18 h) of the cultures with the PrP Sc liposome preparation (30 ng/ml of PrP Sc ) or sulfated colominic acid (3 mg/ml); the percentage of GFAP-positive cells in the cultures amounted to 4 ± 6%.
Neuroprotective effect on gp120-treated neuronal cultures Rat cortical cells undergo apoptosis also following incubation with the HIV-1 coat protein gp120 in vitro. At a concentration of 20 ng/ml, gp120 increased the amount of soluble DNA-histone complexes (apoptosis) by about 5 ± 6-fold compared to untreated control (P50.01; Figures 2A and 5A) ; simultaneously the cell viability (A 595 nm value) decreased by about 60% (Figures 2B and 5B) . Also, this effect was abolished by addition of sulfated colominic acid. Preincubation of the cultures with 0.3 to 3 mg/ml of sulfated colominic acid resulted in a signi®cant (P50.01) reduction of the gp120-induced apoptosis (decrease in the amount of soluble DNA-histone complexes (A 405 nm values) by 53 ± 68%; Figure 5A ). Concomitantly with the decrease in apoptosis in the assays with sulfated colominic acid, the cell viability (A 595 nm value) signi®cantly (P50.01) increased from 41% to 78 ± 90% of A 595 nm value of untreated control without gp120 ( Figure 5B ). A signi®cant (P50.01) reduction of gp120-induced cytotoxicity was also found following pretreatment of gp120 with sulfated colominic acid (1 mg/ml); apoptosis: decrease in A 405 nm value of gp120-treated cultures from 0.80+0.19 to 0.38+0.04 (A 405 nm value of control cultures without gp120, 0.18+0.03; n=6); cell viability: increase in A 595 nm value of gp120-treated cultures from 0.29+0.04 to 0.48+0.05 (A 595 nm value of control cultures without gp120, 0.60+0.04; n=6; not shown in Figure 5A and B). Again, a lower neuroprotective effect was observed if the sulfated colominic acid (1 mg/ml) was added to the cells 2 h after addition of gp120 ( Figure 5A and B).
As a control for the speci®city of the interaction between gp120 and neuronal cells, antibodies against gp120 were added. The gp120-mediated toxic effect could be completely abolished by the antibodies with respect to both DNA fragmentation (occurrence of extranuclear mono-and oligonucleosomes) and to cell viability (not shown; see also Ushijima et al, 1995) .
Previously we reported that the lectin from Gerardia savaglia (GL) (M r 32 000; Kljajic et al, 1987) and the lectin from Narcissus pseudonarcissus (NPL) (M r 25 000; Van Damme et al, 1988) , which bind to gp120 with high af®nity , are able to suppress infection of cells with HIV-1 (Weiler et al, 1990; Mu È ller et al, 1988 ) and gp120-induced neurotoxicity (Mu È ller et al, 1992) . As shown in Figure 2 , coincubation of gp120 with a 19-fold (GL) or 24-fold (NPL) molar excess of the lectins compared to gp120 almost totally abolished both gp120-induced apoptosis (P50.01; Figure 2A ) and cell killing (P50.01; Figure 2B) .
Treatment of the cells with gp120 did not signi®cantly affect glial cell proliferation during the incubation period; the percentage of GFAPpositive cells in the cultures before and after the incubation period (18 h) was 5% and 6%, respectively.
Effect on NMDA-caused neuronal cell death The excitatory amino acids, glutamate and NMDA, are known to induce cortical neurons to apoptosis (Kure et al, 1991; Mu È ller et al, 1992 Mu È ller et al, , 1993 . These amino acids activate the NMDA receptor complex, a ligand-gated Ca 2+ channel (Reynolds and Miller, 1990) . Therefore, we determined the effect of the sulfated colominic acid on NMDA-induced neurotoxicity.
As shown in Table 1 , at a concentration of 100 mg/ ml of NMDA the viability of the cells strongly decreased, as determined in MTT assay. If the neurons were pretreated with sulfated colominic acid, no signi®cant alteration of the toxic effect on neurons caused by NMDA was observed (Table 1) . From this result we conclude that sulfated colominic acid does not act as NMDA receptor antagonist at concentrations of up to 3 mg/ml when coadministered with 100 mg/ml of NMDA. Figure 5 Neuroprotective effect of sulfated colominic acid on gp120-induced cytotoxic effect on rat cortical cells in vitro. Cells were preincubated with various concentrations of sulfated colominic acid for 30 min (378C) and subsequently incubated in the absence or presence of gp120 for 18 h (®lled bars). In one additional experiment, the sulfated colominic acid (1 mg/ml) was added 2 h after addition of gp120 (open bar). Apoptosis (presence of histone-associated DNA fragments in the cytoplasm) was determined by the celldeath detection ELISA (A) and viability was assayed using the MTT test (B). Six independent experiments were performed; means+s.d. *P50.05, **P50.01 (one-way ANOVA and Scheffe Â's test; compared with gp120-treated cultures without sulfated colominic acid). Where indicated the neurons were pretreated with sulfated colominic acid, MK-801 or memantine for 30 min and subsequently incubated with 100 mg/ml of NMDA. The cells were analyzed for viability (n=6) as described under Materials and methods. The means+s.d. are given.
Suppression of neuronal cell death by sulfated colominic acid H Ushijima et al
In contrast, pretreatment of the neurons with the non-competitive NMDA receptor antagonists, MK-801 (1 and 10 mM) and memantine (5 and 50 mM), abolished the NMDA-caused toxicity (Table 1) .
Cytoprotective effect of sulfated colominic acid on HIV-1-infected CEM cells As shown in Figure 6 , the sulfated colominic acid exhibited a strong cytoprotective effect on HIV-1-infected CEM cells. Addition of 0.3 mg/ml and higher of sulfated colominic acid signi®cantly protected the cells against the cytopathic effect of the virus (5-day incubation period); a 50% protection occurred after preincubation of the cells with 0.43 mg/ml of compound ( Figure 6 ). This effect was only observed if the cells were pretreated with sulfated colominic acid (for 2 h) before infection, but not if the compound was added after infection with HIV-1 (not shown). The dose-response curves showed that the sulfated colominic acid was not toxic to the cells up to the maximum concentration tested of 10 mg/ml (Figure 6 ).
Increasing the infectious dose from 10 to 100 and 1000 virus particles per cell caused only a slight reduction of the cytoprotective effect of sulfated colominic acid after an incubation period of 5 days in MTT assay. The absorbance values at 595 nm in the absence or presence of 3 mg/ml of sulfated colominic acid amounted as follows. Inhibition of HIV-1-induced syncytium formation by sulfated colominic acid Next cell fusion assays were performed to determine the anti-HIV activity of sulfated colominic acid. The results revealed that sulfated colominic acid ef®ciently abolished HIV-1-induced syncytium formation, following co-cultivation of uninfected Molt-3 cells with chronically HIV-1-infected Molt-4 cells. At a concentration of 0.3 mg/ml and higher of sulfated colominic acid, markedly less giant cells were found after 24 h, and those which had been formed, were smaller in size. The results were less pronounced when cells were observed after 48 h under the microscope (results not shown).
Discussion

Both PrP
Sc and the HIV-1 coat protein gp120 induce neurotoxicity in vitro (Lipton et al, 1991; Mu È ller et al, 1992 Mu È ller et al, , 1993 ). Here we demonstrate that the toxic effect displayed by PrP Sc and gp120 can be blocked by sulfated colominic acid. This compound acts neuroprotectively at a concentration of 50.3 mg/ml when preincubated with the neurons or the toxic agents, PrP Sc and gp120. The compound alone, at the concentrations used (up to 3 mg/ml), did not in¯uence the naturally occurring neuronal cell death.
Previously we demonstrated that neuronal cell death induced by PrP Sc or HIV-1 gp120 can be prevented by the NMDA receptor antagonists, memantine and MK-801 (Mu È ller et al, 1992 Ushijima et al, 1993; Perovic et al, 1995) . This result indicates that PrP Sc and gp120 activate NMDA receptors, but the underlying mechanism is poorly understood. Gp120 does not interact with the receptor directly (Savio and Levi, 1993; Ushijima et al, 1993) ; it might act through macrophages, which are present in neuronal cultures at small amounts (Benos et al, 1994) . Likewise, the PrP Scinduced activation of NMDA receptor might be caused by a production of NMDA-like neurotoxins through macrophages or an impairment of the release of growth factors from astrocytes. However, if the neurons were pretreated with sulfated colominic acid, no signi®cant decrease in the toxic effect on neurons caused by NMDA was observed. Therefore we conclude that sulfated colominic acid does not act as NMDA receptor antagonist.
Sulfated colominic acid was found to display a strong cytoprotective effect on cells (human T lymphoblastoid CEM) exposed to HIV-1 in vitro in Suppression of neuronal cell death by sulfated colominic acid H Ushijima et al the concentration range of 0.3 ± 10 mg/ml, con®rm-ing previous results (Yang et al, 1996) ; a 50% protection occurred after preincubation of the cells with 0.43 mg/ml of compound. In the concentration range tested, the compound had no effect on cell growth. The fact that sulfated colominic acid exhibits cytoprotective activity only when preincubated with the cells but not when added to the cells after infection suggests that this non-toxic polyanion prevents the infection of the cells by inhibiting the adsorption of the virus. This assumption is also supported by the results obtained in the syncytium assay. It has been shown that sulfated colominic acid does not affect the expression of CD4 antigen in Tcells (Yang et al, 1996) ; therefore this polymer has been proposed to bind to some other glycoproteins or glycolipids on the cell surface (Yang et al, 1996) , e.g. CD26, a putative co-factor for the virus penetration into CD4 + cells (Callebaut et al, 1993) . Another target for this compound might be the V3 domain of HIV-1 gp120, which has been shown to bind sulfated polysaccharides (Batinic and Robey, 1992; Okada et al, 1995) .
Sulfated colominic acid is a polyanion of sialic acid (N-acetyl-D-neuraminic acid) residues. Several polyanionic glycans exhibit inhibitory activity against prion and retroviral infections. These compounds, e.g. pentosan sulfate and dextran sulfate, have been shown to prolong the incubation time of prion infections in rodents (Diringer and Ehlers, 1991) and to inhibit PrP Sc accumulation in neuroblastoma cells (Caughey and Raymond, 1993) . The sulfated glycans stimulate endocytosis of PrP c in cultured cells (Shyng et al, 1995) . Therefore, these polymers may inhibit PrP Sc propagation by reducing the amount of PrP c on the cell surface. Dextran sulfate, heparin sulfate, chondroitin sulfate, and polysulfated polyxylan also inhibit infection of cells by HIV-1 (Baba et al, 1988; Biesert et al, 1988; Mitsuya et al, 1988) . These compounds were found to abolish HIV-1-induced formation of syncytia and to block the adsorption of the virus to the CD4 + target cells (Baba et al, 1988; Biesert et al, 1988) . The sulfated polyglucan sulphoevernan, another polyanion displaying anti-HIV-activity in vitro, has been shown to act through binding to the virus (Weiler et al, 1990) . Our results revealed that sulfated colominic acid only suppresses PrP Sc and HIV-1 gp120-induced neurotoxicity when preincubated with these toxic agents. Thus, the mechanism of sulfated colominic acid resembles that of sulphoevernan, which inhibits HIV-1 infection by binding to viral gp120.
It is known that nonsulfated glycans are much less effective than the sulfated compounds (Caughey and Raymond, 1993) . Consistently, the anti-HIV-1 activity of sulfated colominic acid was found to be much stronger than that of the non-sulfated polymer (Yang et al, 1996) . Therefore, sulfated colominic acid and not the sulfur-free polymer was used in our experiments.
Both PrP C and PrP Sc , like gp120 (Geyer et al, 1988) , undergo a number of post-translational modi®cations, including the attachment of asparagine-linked complex-type oligosaccharide side chains (Haraguchi et al, 1989) . These oligosaccharides may represent potential binding sites for cellular carbohydrate-binding proteins serving as potential receptors for PrP Sc (Schro È der et al, 1994 (Schro È der et al, , 1998 . Thus, the suppression of PrP Sc -induced apoptosis by sulfated colominic acid may by due to an interference with the binding of PrP Sc to these proteins. However, a competitive inhibition by sulfated colominic acid of the putative interaction between PrP and endogenous sulfated glycosaminoglycans found in the PrP amyloid (Caughey and Raymond, 1993 ) might be possible, too.
There is an urgent need to ®nd out strategies for therapeutical intervention in human prion diseases, especially on the level of neuronal cell death caused by the infectious agent. Likewise, there are no effective treatments of the excessive cell death of neurons and lymphocytes in AIDS patients, a major hallmark of this disease (Ameisen, 1992) . Due to its very low cytotoxicity, sulfated colominic acid may be a promising compound for a potential treatment of dementia in both prion and HIV-1 infections.
Materials and methods
Materials NMDA, glycine, p-aminobenzoic acid, insulin, poly-L-lysine (M r 4300 000), cytosine arabinoside and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) were obtained from Sigma (St. Louis, MO, USA); d] cyclophepten-5,10-imine maleate; dizocilpine] was from Research Biochemical International (Natick, MA, USA); Lglutamine, trypsin and polyclonal antibodies against gp120 (sheep) were from Biochrom (Berlin, Germany); and cell-death detection ELISA kit was from Boehringer Mannheim (Mannheim, Germany). The polyclonal antibody R073 (rabbit) against PrP 27 ± 30 puri®ed from scrapie-infected hamster brains (Serban et al, 1990 ) was a gift from Dr SB Prusiner (University of California, San Francisco). Memantine (1-amino-3, 5-dimethyladamantane) was a gift of Merz & Co. (Frankfurt/M, Germany) .
The lectin from Gerardia savaglia (GL) and the lectin from Narcissus pseudonarcissus (NPL) were puri®ed as described (Kljajic et al, 1987; Van Damme et al, 1988) .
Sulfated colominic acid (Figure 1 ) was obtained from Marukin Shoyu Co. Ltd. (Kyoto, Japan). The sodium salt with an average molecular mass of 24 000 (n&50) was used. The compound was dissolved in Ca 2+ and Mg 2+ -free phosphate-buffered saline (PBS) containing 10% dimethyl sulfoxide at stock concentration of 10 mg/ml and stored at 7208C until use.
Preparation of PrP
Sc and HIV-1 gp120 PrP Sc was puri®ed from scrapie-infected hamster brain as described (Hilmert and Diringer, 1984; Sasaki et al, 1992) . The PrP Sc material was solubilized using a mixture of phosphatidylcholine and the nondenaturing detergent sodium cholate (Gabizon et al, 1987) . The PrP Sc -containing liposome material used contained 10 mg of PrP Sc per milligram of phosphatidylcholine. For negative controls, a detergent liposome extract was prepared from the pelleted fraction from normal uninfected brain lacking PrP Sc in the same way but without proteinase K digestion.
The gp120 was puri®ed from HIV IIIB -infected H9 cells (Popovic et al, 1984) as described (Robey et al, 1986; Matthews et al, 1987) . The preparation was 495% pure as checked by polyacrylamide gel electrophoresis (Mu È ller et al, , 1992 .
Neuronal cells
Rat primary cortical cells were prepared from the brains of 18-day-old Wistar rat embryos as described previously (Perovic et al, 1994 . Brie¯y, after isolation cerebral hemispheres were placed into Hank's balanced salt solution (Biochrom) without Ca 2+ and Mg 2+ . Brain tissue was dissociated using 0.025% of trypsin (10 min; 378C); the proteolytic reaction was stopped by addition of 10% fetal calf serum. The single cell suspension was centrifuged and the pellet containing dissociated neuronal cells was resuspended in Dulbecco's modi®ed Eagle's medium (Sigma), supplemented with 30 mM glucose, 24.5 mM KCl, 7 mM p-aminobenzoic acid, 100 mU/l of insulin, 26 mM NaHCO 3 , 2 mM L-glutamine and 10% fetal calf serum. The cells were seeded into poly-Llysine (5 mg/ml; 200 ml/cm 2 ) coated plastic dishes (Nunc) at a concentration of 2610 5 cells/cm 2 . The cells were kept in an atmosphere of 95% air and 5% CO 2 . To enrich the percentage of neurons the cultures were incubated for 24 h in the presence of 10 mM cytosine arabinoside in order to inhibit glial cell proliferation. Afterwards the cells were maintained in cytosine-arabinoside-free medium/serum. The cultures contained 490% of neurons (immunostaining with anti neuro®lament 68 kDa as marker for neurons); the other cells were astrocytes (immunostaining with anti-glial ®brillary acidic protein, GFAP, for glial cells; Boehringer detection kit) and macrophages (as identi®ed by expression of receptors for the Fc portion of immunoglobulin; Raff et al, 1979) . The viability of the cells was 485% as determined by the trypan blue dye exclusion method. One day later the cells were used for the experiments. 
Treatment of neuronal cells
Treatment with gp120
The neuronal cells were treated with 20 ng/ml of gp120 in Ca 2+ -and Mg 2+ -free PBS containing 25 mM Tris/HCl, pH 7.4, and 15 mM glucose for 2 h at 378C. The sulfated colominic acid was added 30 min prior to the viral protein. After incubation PBS was removed and replaced by growth medium/serum containing the same amount of gp120 and sulfated colominic acid; incubation proceeded for up to 18 h. In a second set of experiments, gp120 (150 ng/ml) was pretreated with 1 mg/ml of sulfated colominic acid for 5 h at 48C prior to addition to the cells. In control experiments, HIV-gp120 (130 ng/ml) was reacted (2 h, 48C) with antibodies against gp120 (10 mg/ml) prior to use in the assay (Mu È ller et al, 1992) .
Treatment with NMDA The neuronal cultures were treated (2 h, 378C) with 100 mg/ml of NMDA (0.68 mM) including 10 mM glycine in Ca 2+ -and Mg 2+ -free PBS containing 25 mM Tris/HCl, pH 7.4, and 15 mM glucose. Where indicated, the cultures were pretreated with sulfated colominic acid, MK-801 or memantine for 30 min before NMDA was added. Following NMDA treatment, PBS was removed and replaced by growth medium/serum; incubation proceeded for 18 h.
CEM cells and virus infection
Human T lymphoblastoid CEM cells were maintained in RPMI 1640 medium (Gibco, Karlsruhe, Germany) supplemented with 10% fetal calf serum at 378C in a humidi®ed 5% CO 2 in air atmosphere. The cells (5610 5 , in 1-ml assays) were infected with 5610 6 HIV-1 particles (strain HIV IIIB produced by chronically infected Molt-4 cells) and cultivated for up to 5 days. The sulfated colominic acid was added at a ®nal concentration of 0.2 to 10 mg/ml 2 h prior to addition of the virus (= day 0) and was present throughout the experiment.
Cell fusion assay Uninfected Molt-3 cells (T-lymphoblastoid cell line; 1.8610 5 cells/assay) were co-cultured with chronically HIV-1-infected Molt-4 cells (3.75610 5 cells/assay) in RPMI 1640 medium supplemented with 10% fetal calf serum in the presence or the absence of 0, 0.1, 0.3, 1.0 and 3.0 mg/ml of sulfated colominic acid for 24 or 48 h. The formation of syncytia (de®ned as 44 nuclei within a common cell membrane) was semiquantitatively scored (Lifson et al, 1986) .
Apoptosis assay
The photometric enzyme immunoassay,`cell-death detection ELISA', which measures apoptosis by quantitating cytoplasmic histone-associated DNA fragments was used. For the assay, the cells were collected by centrifugation at 10006g at room temperature for 10 min. The resulting pellets were treated with lysis buffer according to the instructions of the manufacturer (Boehringer Mannheim) and centrifuged again. The supernatants of the second centrifugation step were assayed for protein (see below) and equalized amounts of supernatants were analyzed for the presence of mono-and oligonucleosomes in the ELISA. Measurements were performed at 405 nm against substrate solution as a blank. The background values (incubation buffer instead of sample solution) were subtracted.
Cell viability
The viability of total cells was determined using the MTT colorimetric assay (Scudiero et al, 1988) , followed by evaluation with an ELISA reader (BioRad 3550, equipped with the program NCIMR IIIB).
Protein concentration
Protein concentrations were estimated by the method of Lowry et al (1951) with bovine serum albumin as a standard.
Statistical analysis
The data are presented as the means+s.d. For the statistical comparisons, one-way analysis of variance (ANOVA), followed by Scheffe Â's test for multiple comparison of means was used (Sachs, 1997) . P values 50.05 were considered to be signi®cant.
Abbreviations
GL, lectin from Gerardia savaglia; HIV-1, human immunode®ciency virus type 1; NMDA, Nmethyl-D-aspartic acid; NPL, lectin from Narcissus pseudonarcissus; PrP C , cellular prion protein; PrP Sc , scrapie prion protein.
